DE69737496D1 - SIALYL-LEWISa UND SIALYL LEWISx EPITOP-ANALOGE - Google Patents

SIALYL-LEWISa UND SIALYL LEWISx EPITOP-ANALOGE

Info

Publication number
DE69737496D1
DE69737496D1 DE69737496T DE69737496T DE69737496D1 DE 69737496 D1 DE69737496 D1 DE 69737496D1 DE 69737496 T DE69737496 T DE 69737496T DE 69737496 T DE69737496 T DE 69737496T DE 69737496 D1 DE69737496 D1 DE 69737496D1
Authority
DE
Germany
Prior art keywords
sialyl
lewisa
lewisx
epitop
analogue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69737496T
Other languages
English (en)
Inventor
Reinhold Oehrlein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glycomimetics Inc
Original Assignee
Glycomimetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycomimetics Inc filed Critical Glycomimetics Inc
Application granted granted Critical
Publication of DE69737496D1 publication Critical patent/DE69737496D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69737496T 1996-01-30 1997-01-17 SIALYL-LEWISa UND SIALYL LEWISx EPITOP-ANALOGE Expired - Lifetime DE69737496D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH23096 1996-01-30
PCT/EP1997/000222 WO1997028173A1 (en) 1996-01-30 1997-01-17 SIALYL-LEWISa AND SIALYL-LEWISx EPITOPE ANALOGUES

Publications (1)

Publication Number Publication Date
DE69737496D1 true DE69737496D1 (de) 2007-05-03

Family

ID=4182259

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69737496T Expired - Lifetime DE69737496D1 (de) 1996-01-30 1997-01-17 SIALYL-LEWISa UND SIALYL LEWISx EPITOP-ANALOGE

Country Status (6)

Country Link
US (1) US6169077B1 (de)
EP (1) EP0886640B1 (de)
AT (1) ATE357452T1 (de)
AU (1) AU1542397A (de)
DE (1) DE69737496D1 (de)
WO (1) WO1997028173A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1001961T3 (da) * 1997-08-08 2005-05-23 Aventis Pharma Gmbh Substituerede derivater af tetrahydrofuran og fremgangsmåde til deres fremstilling
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof
US7481790B2 (en) * 2000-12-27 2009-01-27 Advanced Cardiovascular Systems, Inc. Vessel enlargement by arteriogenic factor delivery
AU2003249641B2 (en) 2002-05-16 2009-08-20 Glycomimetics, Inc. Compounds and methods for inhibiting selectin-mediated function
AU2003245595A1 (en) * 2002-07-03 2004-01-23 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis
JP2006515306A (ja) * 2002-12-20 2006-05-25 グリコミメティクス, インコーポレイテッド Pseudomonas細菌感染の処置のためのオリゴ糖およびその結合体
US20040219158A1 (en) * 2003-05-02 2004-11-04 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
JP2007524658A (ja) * 2003-11-19 2007-08-30 グリコミメティクス, インコーポレイテッド E−およびp−セレクチンの両方のための糖模倣物アンタゴニスト
ATE383367T1 (de) * 2003-11-19 2008-01-15 Glycomimetics Inc Spezifischer antagonist sowohl für e- als auch p- selektine
US8201377B2 (en) * 2004-11-05 2012-06-19 Faus Group, Inc. Flooring system having multiple alignment points
US20090036386A1 (en) * 2005-05-25 2009-02-05 Glycomimetics, Inc Heterobifunctional compounds for selectin inhibition
US7517980B2 (en) * 2005-08-09 2009-04-14 Glycomimetics, Inc. Glycomimetric inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from Pseudomonas
SI2264043T1 (en) 2005-09-02 2018-01-31 Glycomimetics, Inc. HETEROBIFUNCTIONAL PAN-SELECTINE INHIBITORS
WO2007143052A1 (en) * 2006-06-01 2007-12-13 Glycomimetics, Inc. Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
WO2008060378A2 (en) 2006-10-12 2008-05-22 Glycomimetics, Inc. Glycomimetic replacements for hexoses and n-acetyl hexosamines
EP2457573A1 (de) * 2007-02-09 2012-05-30 GlycoMimetics, Inc. Verfahren zur Verwendung von Glykomimetika für Hexosen und N-Acetyl-Hexosamine
US8039442B2 (en) 2007-07-18 2011-10-18 Glycomimetics, Inc. Compounds and methods for treatment of sickle cell disease or complications associated therewith
US8895510B2 (en) * 2008-04-08 2014-11-25 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
AU2009257536B2 (en) * 2008-06-13 2015-07-02 Glycomimetics, Inc. Treatment of cancers of the blood using selected glycomimetic compounds
CN102421441B (zh) * 2009-05-01 2015-04-01 糖模拟物有限公司 E-选择蛋白和cxcr4趋化因子受体的异双功能抑制剂
WO2012037034A1 (en) 2010-09-14 2012-03-22 Glycomimetics, Inc. E-selectin antagonists
JP2015500887A (ja) 2011-12-22 2015-01-08 グリコミメティクス, インコーポレイテッド E−セレクチンアンタゴニスト化合物、組成物および使用方法
GB201214736D0 (en) 2012-08-17 2012-10-03 Isis Innovation Inflammation imaging and therapy
HUE038423T2 (hu) 2012-12-07 2018-10-29 Glycomimetics Inc E-szelektin antagonistákat felhasználó vegyületek, készítmények és eljárások vérképzõ sejtek mobilizációjára
PT3227310T (pt) 2014-12-03 2019-11-06 Glycomimetics Inc Inibidores heterobifuncionais de e-selectinas e recetores de quimiocina cxcr4
CA3009836A1 (en) 2016-01-22 2017-07-27 Glycomimetics, Inc. Glycomimetic inhibitors of pa-il and pa-iil lectins
US11291678B2 (en) 2016-03-02 2022-04-05 Glycomimetics, Inc Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin
EP3497131B1 (de) 2016-08-08 2022-03-09 GlycoMimetics, Inc. Kombination von t-zell-checkpoint-inhibitoren mit e-selectin- oder cxcr4-inhibitoren oder mit heterobifunktionellen e-selectin- wie auch cxcr4-inhibitoren
KR102653723B1 (ko) 2016-10-07 2024-04-01 글리코미메틱스, 인크. 매우 강력한 다량체성 e-셀렉틴 길항물질
US11197877B2 (en) 2017-03-15 2021-12-14 Glycomimetics. Inc. Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonists
US11712446B2 (en) 2017-11-30 2023-08-01 Glycomimetics, Inc. Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
CA3085356A1 (en) 2017-12-29 2019-07-04 Glycomimetics, Inc. Heterobifunctional inhibitors of e-selectin and galectin-3
BR112020018184A2 (pt) 2018-03-05 2021-02-02 Glycomimetics, Inc. usos de compostos
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925796A (en) * 1986-03-07 1990-05-15 Massachusetts Institute Of Technology Method for enhancing glycoprotein stability
SE9301677L (sv) 1993-05-14 1994-11-18 Kurt G I Nilsson Syntesmetod
WO1994026760A1 (en) 1993-05-14 1994-11-24 Cytel Corporation SIALYL Lex ANALOGUES AS INHIBITORS OF CELLULAR ADHESION

Also Published As

Publication number Publication date
US6169077B1 (en) 2001-01-02
EP0886640B1 (de) 2007-03-21
ATE357452T1 (de) 2007-04-15
WO1997028173A1 (en) 1997-08-07
EP0886640A1 (de) 1998-12-30
AU1542397A (en) 1997-08-22

Similar Documents

Publication Publication Date Title
ATE357452T1 (de) Sialyl-lewisa und sialyl lewisx epitop-analoge
ATE397005T1 (de) Sialyl-lewisa und sialyl-lewisx epitope analoge
MX9709351A (es) Derivados de alfa-hordotionina con alto contenido de treonina.
ES2128097T3 (es) Combinaciones de herbicidas de sulfonilurea con antidotos.
DK0386997T3 (da) Anvendelse af 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamin-derivater i behandlingen af psykose, inflammation og som immunosuppressive midler
MX9709352A (es) Derivados de alfa-hortodionina con alto contenido de metionina.
AU3495395A (en) Cyclic cs-1 peptidomimetics, compositions and methods of using the same
NO974510L (no) Synergistiske blandinger av zidovudin, 1592U89 og 3TC eller FTC
AU1198697A (en) Stabilizers for live vaccines
BR8802492A (pt) Composicao esterilizante e de alto grau desinfetante,inodora
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
DE69425433D1 (de) Getränke-stabilisierungssystem
CA2075060A1 (en) Novel vehicle gases and their use in medical preparations
BR9510604A (pt) Aperfeiçoamento do rendimento de plantas
NO904676D0 (no) Optisk forsterkningsenhet med lav stoey og med refleksjon av den pumpende effekt.
NO975557L (no) Immortalisering og dissimortalisering av celler
BR9711117A (pt) Oligossacarídios modificados.
ES2106920T3 (es) Composicion que permite estabilizar termicamente las proteinas y producto obtenido de este modo.
ES2167748T3 (es) Derivados del polisacarido k5 con actividad anticoagulante.
DE69132922D1 (de) System zur Erzeugung von Stosswellen, welches eine Anzeige des effektiven Stosswellenbereichs erlaubt
FI895039A0 (fi) Metoder foer behandling och foerebyggande av pneumocystis carinii-lunginflammation och andra sjukdomar samt foereningar och kompositioner, som anvaends i naemnda metoder.
EP1666057A3 (de) Ein azellulärer Impfstoff der Bordetella pertussis Antigene enthält
NO984760L (no) Anvendelse av en osmolytt ved behandling av effekter forÕrsaket av en infeksjon, en inflammasjon eller en immundysfunksjon
ITRM930797A0 (it) Procedimento e dispositivo per la fabbricazione di vetro piano con caratteristiche migliorate.
DK0831722T3 (da) Gelsystem, som omfatter carrageenan og kokosnødendosperm

Legal Events

Date Code Title Description
8332 No legal effect for de